Introduction and Aim: The health advantages, enhanced organoleptic features, and global economic significance of probiotic-enriched food items have motivated researchers to discover novel probiotics. In light of this, a study was performed to assess the probiotic potential of five Bacillus strains isolated from the ovaries of 8-week-old mice in a previous study.
Materials and Methods: The five Bacillus strains were appraised for their probiotic potentials, such as tolerance to acidic pH, bile salt, and phenol. The haemolytic behaviour, antibiotic sensitivity characteristics, and capacity to produce amylase, protease and L-asparaginase were also assessed.
Results: All the isolates exhibited high survival in simulated gastric juice conditions such as pepsin containing acidic pH environments, up to 1% bile, and 0.5% phenol. Bacillus cereus OM02 and Bacillus velezensis OM03 exhibited the highest tolerance, with 50 % of survival at pH 2.5 and 1% bile salt-containing media. All the isolates were found to be amylase and protease producers and non-beta-haemolytic, however, OM02 and OM04 were beta-haemolytic. Extracts from the strain OM03 also exhibited dosage-dependent ferric-reducing antioxidant power. Except for OM04, which is resistant to ampicillin and sulphatriad, and OM01 and OM02, which are sulphatriad-resistant, all isolates were susceptible to most antibiotics. This is the first study on Bacillus species from Swiss albino mouse ovarian to evaluate probiotic potential.
Conclusion: These findings suggest that Bacillus velezensis OM03, Bacillus aerius OM01, and Bacillus subtilis OM05 are suitable probiotic candidates and may be used in both animal and human formulations to improve consumer health.